Effects of exogenous growth hormone on resting pulmonary function in children with thermal injury.
Burned children living beyond the acute phase of injury often have extensive physical functional limitations, such as impaired spirometry pulmonary function (PF). In patients with both lung disease and nutritional compromise, such as cystic fibrosis, studies suggest that growth hormone (GH) therapy improves PF. However, whether GH will improve PF in burned children is presently unknown. We therefore evaluated whether GH administration of 0.05 mg/kg/day for 1 year would improve PF in burned children. Thirty children, aged 7 to 18, with a 40% or more total body surface area burned were randomized into two groups and studied. One group received GH (n = 17) and the other received saline (n = 13). No differences were noted at hospital discharge between groups in age, % total body surface area, height, and weight. At 12 months after burn, both groups had similar height and weight. Baseline PF were below normal in both groups, but no statistical differences were noted between groups. At 1 year, there was a significant increase in PF in both groups; however, this increase in PF was similar in both groups. We conclude that the response in PF in burned children from the administration of GH prescribed for up to 1 year is limited.
Suman
Oscar E
OE
Medical Staff Administration, Shriners Hospitals for Children and Department of Surgery, The University of Texas Medical Branch, Galveston, Texas 77550, USA.
Mlcak
Ronald P
RP
Herndon
David N
DN
D000293:Adolescent; D002056:Burns / Q000150:complications*; D002648:Child; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology / Q000627:therapeutic use*; D008168:Lung / Q000187:drug effects; D055370:Lung Injury; D008297:Male; D011659:Pulmonary Gas Exchange / Q000187:drug effects*; D012129:Respiratory Function Tests; D012131:Respiratory Insufficiency / Q000188:drug therapy* / Q000209:etiology; D011795:Surveys and Questionnaires
D007334:Insulin-Like Growth Factor I